πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine β€” grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≀24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β€” use filters for patent-cliff planning.

Page 6 of 15

  1. US 10874649

    2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10870645

    Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10864217

    Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10858436

    PSGL-1 modulators and uses thereof

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10851112

    Anti-HCMV virus compound

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10836728

    Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10836741

    Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10829460

    [6,6] fused bicyclic HDAC8 inhibitors

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10829462

    3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10829461

    3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10822316

    3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10808004

    Triterpene-glycoside as sweetener or sweetener enhancer

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10780074

    Compounds and uses thereof

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10781189

    1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10774092

    ULK1 inhibitors and methods using same

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10766903

    Piperidine derivatives as inhibitors of ubiquitin specific protease 7

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10765600

    Adapter for use in a planetary mixer

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10766902

    Wee-1 inhibiting pyrazolopyrimidinone compounds

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10759863

    Modulation of Ξ³Ξ΄ T cells

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10717720

    Modified compound of andrographolide

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10716782

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10716808

    Methods and compositions to modulate hair growth

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10717765

    Compositions and methods for treating autoimmune and inflammatory disorders

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10703735

    4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10696654

    Therapeutic compounds

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10689397

    ULK1 inhibitors and methods using same

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10689347

    Substituted heterocyclyl derivatives as CDK inhibitors

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10683283

    Substituted ureas and methods of making and using same

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10682416

    Epicardial-derived paracrine factors for repairing cardiac tissue

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10676474

    1,6-naphthyridine derivatives as CDK4/6 inhibitor

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10669311

    Targeted delivery system and methods of use therefor

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10668055

    Cancer treatment using combinations of ERK and RAF inhibitors

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10653173

    Method for masking unpleasant taste

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10653797

    Compounds and compositions for targeting brain injuries and methods of use thereof

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10653172

    Natural stilbenes as sweeteners or sweetener enhancer

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10647710

    Thiazole derivative and applications thereof

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10647689

    Apelin receptor agonists and methods of use thereof

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10639348

    Peptides with anti-cancer activity

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10640517

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10633351

    Halogenated compound and axially chiral isomer thereof

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10633632

    Human disc tissue

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10626129

    Heteroaryl inhibitors of PDE4

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10626094

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10626096

    Azole derivatives as apelin receptor agonist

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10617723

    C. novyi for the treatment of solid tumors in humans

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10617673

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10611760

    Therapeutic compounds as inhibitors of the orexin-1 receptor

    Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10597367

    Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.